APA

Brown G. R., Hollinshead D. M., Stokes E. S., Clarke D. S., Eakin M. A., Foubister A. J., Glossop S. C., Griffiths D., Johnson M. C., McTaggart F., Mirrlees D. J., Smith G. J. & Wood R. (19990520). Quinuclidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase: optimization from lipid profiles. : Journal of medicinal chemistry.

Chicago

Brown G R, Hollinshead D M, Stokes E S, Clarke D S, Eakin M A, Foubister A J, Glossop S C, Griffiths D, Johnson M C, McTaggart F, Mirrlees D J, Smith G J and Wood R. 19990520. Quinuclidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase: optimization from lipid profiles. : Journal of medicinal chemistry.

Harvard

Brown G. R., Hollinshead D. M., Stokes E. S., Clarke D. S., Eakin M. A., Foubister A. J., Glossop S. C., Griffiths D., Johnson M. C., McTaggart F., Mirrlees D. J., Smith G. J. and Wood R. (19990520). Quinuclidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase: optimization from lipid profiles. : Journal of medicinal chemistry.

MLA

Brown G R, Hollinshead D M, Stokes E S, Clarke D S, Eakin M A, Foubister A J, Glossop S C, Griffiths D, Johnson M C, McTaggart F, Mirrlees D J, Smith G J and Wood R. Quinuclidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase: optimization from lipid profiles. : Journal of medicinal chemistry. 19990520.